From Financial Modeling Prep: 2025-06-17 16:19:00

Truist Securities lowered Humana’s price target to $280 from $305, maintaining a Hold rating due to valuation adjustments despite positive updates from Investor Day. Momentum in Medicare Advantage and Medicaid operations, along with growth opportunities at Centerwell, were highlighted. Management’s strategic roadmap through 2028 focuses on enhancing operating leverage and performance in key segments.



Read more at Financial Modeling Prep:: Truist Trims Humana Price Target Despite Positive …